BioCentury
ARTICLE | Company News

FirstString Research, Relief Therapeutics deal

August 8, 2016 7:00 AM UTC

Relief will acquire dermatology company FirstString in a stock deal. FirstString’s Granexin Gel, a bioengineered peptide gel mimetic of the carboxyl-terminus of gap junction protein alpha 1, 43kDa (G...